SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending as speculation mounts around potential cannabis rescheduling, possibly driven by an upcoming address from President Trump. The community is buzzing with anticipation, with some envisioning a significant price surge, reminiscent of past rallies, while others remain cautious about potential volatility and market manipulation in the sector. Many are pointing to credible news outlets reporting on the possibility of an executive order regarding reclassification.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla's stock is trending as it approaches all-time highs, fueled by optimism surrounding the company's robotaxi initiatives and expansion plans. Bullish sentiment is reflected in options activity, while some traders express skepticism regarding the company's valuation and reliance on future technologies. Community discussions also highlight Elon Musk's influence and the stock's historical volatility, creating a debate between long-term potential and short-term risks.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as community members draw parallels to Bitcoin, touting it as a culture coin with the potential to reach significant highs. The coin, built on the Solana network, is fostered by an active community, and its advocates emphasize its connection to cannabis culture and potential role in a greener future. The community highlights the coin's focus on creativity, positivity, innovation, and connections.

First Trust Exchange-Traded Fund III - First Trust Cloud Computing ETF

SKYY is trending as investors monitor the performance of cloud computing stocks amidst various earnings reports and industry developments. Community discussions revolve around potential breakout opportunities and the ETF's relative strength compared to the broader market. Some analysts suggest a constructive outlook for the cloud computing sector.

First Majestic Silver Corp. engages in the production, development, exploration and acquisition of mineral properties. It owns and operates producing mines in México including the La Encantada Silver Mine, La Parrilla Silver Mine, San Martin Silver Mine, La Guitarra Silver Mine, Del Toro Silver Mine, Santa Elena Silver & Gold Mine, and San Dimas Silver & Gold Mine. The company was founded by Keith Neumeyer on September 26, 1979 and is headquartered in Vancouver, Canada.

First Majestic Silver Corporation

First Majestic Silver ($AG) is trending as silver prices surge to new highs, sparking discussions about potential breakouts and significant gains. Community members are actively analyzing chart patterns and expressing excitement over silver's momentum, while also debating the impact of factors like Comex activity and future earnings. Investors are closely watching for a potential run to new highs, with some suggesting that $AG is significantly undervalued given current silver prices.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending as anticipation builds for an upcoming FDA meeting, with the community actively discussing potential outcomes and speculating on a possible buyout.  Community members are optimistic, referencing strong data and Merck's previous interest, while also watching for news and potential catalysts. Some traders are closely watching volume and share price action.

Hycroft Mining Holding Corp. engages in the exploration, mining, and development of gold and silver properties. The company was founded on August 28, 2017 and is headquartered in Winnemucca, NV.

Hycroft Mining Holding Corporation - Ordinary Shares - Class A

HYMC is trending as precious metals prices rise, with silver nearing all-time highs, sparking excitement about the potential value of its silver deposits. The community is closely watching major shareholders like Eric Sprott, noting his continued investment and potential influence on the company's direction. Discussions also highlight the company's debt-free status and anticipation for upcoming technical reports.

Centene Corp. is a healthcare enterprise, which engages in the provision of programs and services to government sponsored healthcare programs. It operates through the following segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment includes the Temporary Assistance for Needy Families program, Medicaid Expansion programs, the Aged, Blind or Disabled program, the Children's Health Insurance Program, Long-Term Services and Supports, Foster Care, Medicare-Medicaid Plans, which cover beneficiaries who are dually eligible for Medicaid and Medicare, and other state-based programs. The Medicare segment consists of Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans, and Medicare Prescription Drug Plans. The Commercial segment is involved in the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products. The Other segment refers to pharmacy operations, Envolve Benefit Options’ vision and dental services, clinical healthcare, behavioral health, the TRICARE program, and corporate management companies. The company was founded in 1984 and is headquartered in St. Louis, MO.

Centene Corp.

Centene ($CNC) is trending as discussions revolve around the potential impact of ACA subsidy extensions and the company's recent earnings beat, with community members weighing the likelihood of government action and its effect on the healthcare sector; also being discussed is a proposed change where money for healthcare subsidies would go directly to the people instead of insurance companies. Bullish sentiment is building as some anticipate a positive shift, while others remain cautious due to political uncertainties and potential policy changes.

Vanguard Group, Inc. - Vanguard Extended Market Index ETF

Vanguard Extended Market ETF

VXF is currently trending as investors assess the potential rotation from megacaps into small and mid-cap stocks, with some analysts pointing towards an oversold market and dip-buying opportunities. Community members are actively discussing technical indicators, potential entry points based on imbalances and Fibonacci levels, and Q4 performance expectations. Several bullish alerts indicate a possible breakout, though concerns remain about interest rates and economic data.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave's recent struggles are the focus as the stock trends downwards, with investors expressing concerns about AI spending and construction delays. Community members are closely watching key support levels, debating whether the dip presents a buying opportunity or signals deeper issues related to debt and profitability. Some are pointing to insider selling, while others highlight Ark Invest's continued accumulation of shares.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 30,011 Shares

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 30,011 shares of BridgeBio Pharma stock in a transaction dated Monday, December 15th. The stock was sold at an average price...

Castleark Management LLC Cuts Position in BridgeBio Pharma, Inc. $BBIO

Castleark Management LLC trimmed its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 27.2% in the second quarter, according to its most recent disclosure with the...

Gilder Gagnon Howe & Co. LLC Boosts Stake in BridgeBio Pharma, Inc. $BBIO

Gilder Gagnon Howe & Co. LLC grew its holdings in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 280.7% in the 2nd quarter, according to its most recent disclosure with the...

Eventide Asset Management LLC Decreases Stake in BridgeBio Pharma, Inc. $BBIO

Eventide Asset Management LLC cut its stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 27.8% during the second quarter, according to its most recent Form 13F filing with the...

Frontier Capital Management Co. LLC Sells 233,538 Shares of BridgeBio Pharma, Inc. $BBIO

Frontier Capital Management Co. LLC lowered its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 30.4% during the 2nd quarter, according to the company in its most recent disclosure...

BridgeBio Pharma (NASDAQ:BBIO) CAO Maricel Apuli Sells 2,000 Shares of Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of the stock in a transaction on Monday, December 8th. The shares were sold at an average price of $74.26...

HighVista Strategies LLC Increases Stock Position in BridgeBio Pharma, Inc. $BBIO

HighVista Strategies LLC raised its position in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 45.2% during the second quarter, according to its most recent disclosure with the Securities and...

BridgeBio Pharma (NASDAQ:BBIO) CAO Sells $148,520.00 in Stock

BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CAO Maricel Apuli sold 2,000 shares of BridgeBio Pharma stock in a transaction that occurred on Monday, December 8th. The shares were sold at an...

Stempoint Capital LP Reduces Stock Holdings in BridgeBio Pharma, Inc. $BBIO

Stempoint Capital LP cut its holdings in BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) by 73.8% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange...

89,312 Shares in BridgeBio Pharma, Inc. $BBIO Acquired by WINTON GROUP Ltd

WINTON GROUP Ltd bought a new stake in shares of BridgeBio Pharma, Inc. (NASDAQ:BBIO - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund bought...

BridgeBio Pharma, Inc. engages in identifying and advancing transformative medicines to treat patients who suffer from Mendelian diseases. Its pipeline of development programs includes product candidates ranging from early discovery to late-stage development. The company was founded by Charles Homcy, Francis Patrick McCormick, Philip Reilly, and Neil Kumar in 2015 and is headquartered in Palo Alto, CA.

BridgeBio Pharma Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

Current Price	$75.00
Prev Close	$74.51
Open	$73.49
Dividend Yield	0.00%
50-Day Moving Average	$64.58
Beta	1.35
Avg. Volume	2.2M
PE Ratio	-18.08

52-Week High	$76.51
52-Week Low	$25.34
Market Capitalization	$14.82B
EPS (Annual)	-$2.88
Price to Book	-7.54
Revenue Per Employee	$303,975.34
Enterprise Value/EBITDA	N/A

BBIO
BridgeBio Pharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BBIO News

BBIOBridgeBio Pharma Inc